Bilcare Ltd

At Rs 107.62, the buying was done — not because demand dried up, but because the exchange wouldn't let the stock go any higher. Bilcare Ltd locked at its upper circuit of 2.44% on 18 Sep 2026, with buyers queuing and no sellers willing to part with shares.

Bilcare Ltd, a micro-cap player in the Healthcare Services sector, has seen its investment rating upgraded from Sell to Hold as of 17 September 2026. This change reflects a marked improvement in the company’s technical indicators, alongside encouraging financial results and a fair valuation relative to its peers. Despite some lingering concerns over long-term fundamentals and debt levels, the stock’s recent market-beating returns and positive momentum have prompted a reassessment of its outlook.

At Rs 102.5, the buying was done — not because demand dried up, but because the exchange wouldn't let the stock go any higher. Bilcare Ltd locked at its upper circuit of 5.0% on 17 Sep 2026, with buyers queuing and no sellers willing to part with shares.

At Rs 92.69, sellers were still queuing — but there were no buyers willing to take the other side. Bilcare Ltd locked at its lower circuit of 4.99% on 16 Sep 2026, with unfilled sell orders and a frozen price, signalling a pronounced imbalance in supply and demand.

At Rs 97.56, the buying was done — not because demand dried up, but because the exchange wouldn't let the stock go any higher. Bilcare Ltd locked at its upper circuit of 5% on 15 Sep 2026, with buyers queuing and no sellers willing to part with shares.

At Rs 95.61, sellers were still queuing — but there were no buyers willing to take the other side. Bilcare Ltd locked at its lower circuit of 5.0% on 8 Sep 2026, with unfilled sell orders and a frozen price, reflecting persistent selling pressure in a micro-cap stock with limited liquidity.

Bilcare Ltd, a micro-cap player in the healthcare services sector, has seen its investment rating downgraded from Hold to Sell as of 7 September 2026. This shift reflects a nuanced reassessment across four critical parameters: quality, valuation, financial trend, and technicals. Despite a fair valuation and recent positive financial results, concerns over long-term fundamentals and weakening technical indicators have prompted a more cautious stance.

At Rs 100.64, the buying was done — not because demand dried up, but because the exchange wouldn't let the stock go any higher. Bilcare Ltd locked at its upper circuit of 5.0% on 7 Sep 2026, with buyers queuing and no sellers willing to part with shares.

At Rs 95.85, the buying was done — not because demand dried up, but because the exchange wouldn't let the stock go any higher. Bilcare Ltd locked at its upper circuit of 5% on 4 Sep 2026, with buyers queuing and no sellers willing to part with shares.

Bilcare Ltd, a micro-cap player in the healthcare services sector, has seen its investment rating upgraded from Sell to Hold as of 2 September 2026. This revision reflects a combination of improved technical indicators, a more attractive valuation profile, and positive financial trends, despite some lingering fundamental challenges. The stock’s recent performance and market context underpin this nuanced reassessment by MarketsMOJO.

Bilcare Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 02 June 2026. However, the analysis and financial metrics discussed here reflect the company’s current position as of 01 September 2026, providing investors with an up-to-date view of the stock’s fundamentals, valuation, financial trends, and technical outlook.

Bilcare Ltd, a micro-cap player in the healthcare services sector, has seen a notable shift in its valuation parameters, moving from fair to expensive territory. This change, coupled with a recent downgrade in its Mojo Grade from Strong Sell to Sell, raises questions about the stock’s price attractiveness relative to its historical averages and peer group benchmarks.

The 50-day moving average has crossed above the 200-day moving average for Bilcare Ltd, signalling a golden cross on 31 Aug 2026. Yet, the stock declined 1.11% on the day the cross formed, and monthly technical indicators remain bearish. This divergence between the moving averages and price action calls for a detailed examination of the signal's reliability.

At Rs 93.42, sellers were still queuing — but there were no buyers willing to take the other side. Bilcare Ltd locked at its lower circuit of 5% on 25 Aug 2026, with unfilled sell orders and a frozen price, signalling persistent selling pressure in this micro-cap healthcare services stock.

Bilcare Ltd, a micro-cap player in the Healthcare Services sector, has seen its valuation parameters shift notably, moving from fair to expensive territory. This change, coupled with a recent upgrade in its Mojo Grade from Strong Sell to Sell, highlights evolving market perceptions and raises questions about the stock’s price attractiveness relative to its historical averages and peer group.